Search
Displaying results 721 - 730 of 10000 in total
Adenosine-5'-Propylphosphate
go.drugbank.com/drugs/DB03230ExperimentalSynonyms: Adenosine-5'-PropylphosphateRibose-5-phosphate
go.drugbank.com/drugs/DB02053ExperimentalSynonyms: 5-O-phosphono-D-ribose, D-Ribose 5-phosphateDeoxyuridine-5'-Triphosphate
go.drugbank.com/drugs/DB02333ExperimentalSynonyms: Deoxyuridine-5'-TriphosphateDeoxyuridine-5'-Diphosphate
go.drugbank.com/drugs/DB03413ExperimentalSynonyms: Deoxyuridine-5'-DiphosphatePseudouridine-5'-Monophosphate
go.drugbank.com/drugs/DB03829ExperimentalSynonyms: Pseudouridine-5'-Monophosphate5-phenylpentanoic acid
go.drugbank.com/drugs/DB04051ExperimentalSynonyms: 5-Phenylvaleric acid, δ-phenylvaleric acid5-Aminoimidazole Ribonucleoside
go.drugbank.com/drugs/DB04568ExperimentalSynonyms: 5-Aminoimidazole Ribonucleoside5-hydroxyvaleric acid
go.drugbank.com/drugs/DB04781ExperimentalSynonyms: 5-hydroxy-pentansäure, 5-hydroxyvaleric acidCeritinib
go.drugbank.com/drugs/DB09063ApprovedInvestigationalThe FDA approved ceritinib in April 2014 due to a surprisingly high response rate (56%) towards crizotinib-resistant tumours and has designated it with orphan drug status. … Following treatment with crizotinib (a first-generation ALK inhibitor), most tumours develop drug resistance due to mutations in key "gatekeeper" residues of the enzyme.
Categories: Heterocyclic Compounds, 1-Ring, P-glycoprotein substrates with a Narrow Therapeutic IndexSynonyms: N-{2-[(5-chloro-2-{[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}propane-2-sulfonamide